BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18346129)

  • 1. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.
    Su CW; Hung HH; Huo TI; Huang YH; Li CP; Lin HC; Lee PC; Lee SD; Wu JC
    Liver Int; 2008 Nov; 28(9):1305-13. PubMed ID: 18346129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.
    Reisman Y; van Dam GM; Gips CH; Lavelle SM; Euricterus PM
    Hepatogastroenterology; 1997; 44(16):982-9. PubMed ID: 9261586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
    Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
    Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
    Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
    Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
    ter Borg PC; Schalm SW; Hansen BE; van Buuren HR;
    Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and prognosis of primary biliary cirrhosis in Korea].
    Kim KA; Jeong SH; Lee JI; Yeon JE; Lee HJ; Kwon SY; Chang UI; Min HJ
    Korean J Hepatol; 2010 Jun; 16(2):139-46. PubMed ID: 20606498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study.
    van Dam GM; Gips CH; Reisman Y; Maas KW; Purmer IM; Huizenga JR; Verbaan BW
    Hepatogastroenterology; 1999; 46(25):108-15. PubMed ID: 10228773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score.
    Chan AW; Chan RC; Wong GL; Wong VW; Choi PC; Chan HL; To KF
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1391-6. PubMed ID: 25753927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
    Kilmurry MR; Heathcote EJ; Cauch-Dudek K; O'Rourke K; Bailey RJ; Blendis LM; Ghent CN; Minuk GY; Pappas SC; Scully LJ; Steinbrecher UP; Sutherland LR; Williams CN; Worobetz LJ
    Hepatology; 1996 May; 23(5):1148-53. PubMed ID: 8621147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.
    Kim WR; Poterucha JJ; Wiesner RH; LaRusso NF; Lindor KD; Petz J; Therneau TM; Malinchoc M; Dickson ER
    Hepatology; 1999 Jun; 29(6):1643-8. PubMed ID: 10347102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group.
    Poupon RE; Bonnand AM; Chrétien Y; Poupon R
    Hepatology; 1999 Jun; 29(6):1668-71. PubMed ID: 10347106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of pruritus in primary biliary cirrhosis.
    Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates.
    Kim WR; Wiesner RH; Poterucha JJ; Therneau TM; Benson JT; Krom RA; Dickson ER
    Liver Transpl; 2000 Jul; 6(4):489-94. PubMed ID: 10915173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?
    Krzeski P; Zych W; Kraszewska E; Milewski B; Butruk E; Habior A
    Hepatology; 1999 Oct; 30(4):865-9. PubMed ID: 10498635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation.
    van Dam GM; Verbaan BW; Therneau TM; Dickson ER; Malinchoc M; Murtaugh PA; Huizenga JR; Gips CH
    Hepatogastroenterology; 1997; 44(15):732-43. PubMed ID: 9222682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population.
    Wong RK; Lim SG; Wee A; Chan YH; Aung MO; Wai CT
    J Gastroenterol Hepatol; 2008 Apr; 23(4):599-605. PubMed ID: 17645483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study.
    Spadaro A; Luigiano C; De Caro G; Morace C; Tortorella V; Bonfiglio C; Pagano N; Consolo P; Alibrandi A; Ajello A; Ferraù O; Freni MA
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):311-9. PubMed ID: 18043549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.